BTT-266 is an antagonist for calcium channel , through suppression of the Ca V α 1-AID -Ca V β 3 interaction, with a K i of 1.4 μM. BTT-266 modulates the activation of voltage-dependent Ca V 2.2. BTT-266 exhibits analgesic efficacy against neuropathic pain in rats model.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Hypertension | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Calcium Channel
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。